Cognitive and other neuropsychiatric symptoms in COVID-19: analysis of person-generated longitudinal health data from a community-based registry

Abstract

Objective To describe cognitive symptoms in people not hospitalised at study enrolment for SARS-CoV-2 infection and associated demographics, medical history, other neuropsychiatric symptoms and SARS-CoV-2 vaccination.Design Longitudinal observational study.Setting Direct-to-participant registry with community-based recruitment via email and social media including Google, Facebook and Reddit, targeting adult US residents. Demographics, medical history, COVID-19-like symptoms, tests and vaccinations were collected through enrolment and follow-up surveys.Participants Participants who reported positive COVID-19 test results between 15 December 2020 and 13 December 2021. Those with cognitive symptoms were compared with those not reporting such symptoms.Main outcome measure Self-reported cognitive symptoms (defined as ‘feeling disoriented or having trouble thinking’ from listed options or related written-in symptoms)Results Of 3908 participants with a positive COVID-19 test result, 1014 (25.9%) reported cognitive symptoms at any time point during enrolment or follow-up, with approximately half reporting moderate/severe symptoms. Cognitive symptoms were associated with other neuropsychiatric symptoms, including dysgeusia, anosmia, trouble waking up, insomnia, headache, anxiety and depression. In multivariate analyses, female sex (OR, 95% CI): 1.7 (1.3 to 2.2), age (40–49 years (OR: 1.5 (1.2–1.9) compared with 18–29 years), history of autoimmune disease (OR: 1.5 (1.2–2.1)), lung disease (OR: 1.7 (1.3–2.2)) and depression (OR: 1.4 (1.1–1.7)) were associated with cognitive symptoms. Conversely, black race (OR: 0.6 (0.5–0.9)) and COVID-19 vaccination before infection (OR: 0.6 (0.4–0.7)) were associated with reduced occurrence of cognitive symptoms.Conclusions In this study, cognitive symptoms among COVID-19-positive participants were associated with female gender, age, autoimmune disorders, lung disease and depression. Vaccination and black race were associated with lower occurrence of cognitive symptoms. A constellation of neuropsychiatric and psychological symptoms occurred with cognitive symptoms. Our findings suggest COVID-19’s full health and economic burden may be underestimated.Trial registration number NCT04368065.